These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34868205)

  • 1. CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration
    Gao ZW; Liu C; Yang L; Chen HC; Yang LF; Zhang HZ; Dong K
    Front Genet; 2021; 12():728200. PubMed ID: 34868205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calponin 3 suppresses proliferation, migration and invasion of non-small cell lung cancer cells.
    Yang C; Zhu S; Feng W; Chen X
    Oncol Lett; 2021 Aug; 22(2):634. PubMed ID: 34267826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
    Chen J; Chen H; Yang H; Dai H
    Biomed Pharmacother; 2018 Apr; 100():233-239. PubMed ID: 29432994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ; Liu SS; Li BR
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinoma.
    Zhang J; Zhang C; Liu X; Sun N; Zhang C; Li R; Zhang Z
    Transl Cancer Res; 2020 May; 9(5):3293-3302. PubMed ID: 35117696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.
    Li L; Liu YD; Zhan YT; Zhu YH; Li Y; Xie D; Guan XY
    Thorac Cancer; 2018 Jul; 9(7):775-784. PubMed ID: 29722145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma.
    Li P; Chen X; Zhou S; Xia X; Wang E; Han R; Zeng D; Fei G; Wang R
    J Inflamm Res; 2022; 15():4171-4184. PubMed ID: 35912402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMaf-Inducing Protein Promotes LUAD Proliferation and Metastasis by Activating the MAPK/ERK Pathway.
    Yu XY; Wang M; Qian JJ
    Evid Based Complement Alternat Med; 2022; 2022():2501846. PubMed ID: 36159575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma.
    Zhao J; Cheng M; Gai J; Zhang R; Du T; Li Q
    Front Genet; 2020; 11():588499. PubMed ID: 33244319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-depth analysis of immune cell landscapes reveals differences between lung adenocarcinoma and lung squamous cell carcinoma.
    Wang X; Zheng K; Hao Z
    Front Oncol; 2024; 14():1338634. PubMed ID: 38333684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing Focal Adhesion and Epithelial-Mesenchymal Transition.
    Wu Y; Liu L; Shen X; Liu W; Ma R
    Cancer Manag Res; 2021; 13():559-570. PubMed ID: 33519235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
    Zhong K; Yang F; Han Q; Chen J; Wang J
    Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma.
    Xu B; Chen Q; Yue C; Lan L; Jiang J; Shen Y; Lu B
    Oncol Lett; 2018 Sep; 16(3):2935-2948. PubMed ID: 30127882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of m
    Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
    Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromobox Homologue 7 Acts as a Tumor Suppressor in Both Lung Adenocarcinoma and Lung Squamous Cell Carcinoma via Inhibiting ERK/MAPK Signaling Pathway.
    Huang J; Zhang W; Lin D; Lian L; Hong W; Xu Z
    Evid Based Complement Alternat Med; 2022; 2022():4952185. PubMed ID: 35646140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
    Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
    Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
    Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
    Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.